Taken together, the crucial tumor suppressive roles of ARID1A shed light on targeted therapeutic strategies, hence there has been ongoing effort towards developing effective therapeutic strategies for ARID1A deficient tumors (Bitler, Fatkhutdinov & Zhang, 2015; Mathur, 2018; Mullen et al., 2021). This evidence concerns the gene ARID1A and neoplasm.